Financial MarketsTrumpUpdated 3 days ago

Trump Announces Major Price Reductions for Obesity Drugs

President Trump has unveiled a deal to significantly reduce the prices of obesity drugs, making them more accessible to Americans. Partnering with Eli Lilly and Novo Nordisk, the prices for medications like Wegovy and Zepbound will drop to as low as $149 a month. This initiative aims to address rising obesity rates and improve healthcare affordability, particularly for Medicare and Medicaid patients, reflecting a commitment to enhancing health outcomes nationwide.

4articles

Financial MarketsTrump

Updated 3 days ago

Trump Announces Major Price Reductions for Obesity Drugs

The New York Times3 days ago

Trump Announces Deal to Drop Obesity Drug Prices to as Little as $149 a Month

PositiveFinancial Markets

President Trump has made a significant announcement regarding the prices of popular obesity drugs, Wegovy and Zepbound, which will now be available for as low as $149 a month. This deal with pharmaceutical giants Eli Lilly and Novo Nordisk aims to make these medications more accessible for Medicare, Medicaid, and self-paying patients. This move is crucial as it addresses the rising obesity rates in America and provides a more affordable option for those seeking effective weight-loss solutions.

Read full article

via The New York Times

Financial Times3 days ago

US to slash prices of obesity drugs offered on Trump website

PositiveFinancial Markets

The White House has announced a significant price reduction for obesity drugs available on the Trump website, partnering with Novo Nordisk and Eli Lilly to lower costs from over $1,000 to approximately $350. This move is crucial as it makes essential medications more accessible to those struggling with obesity, potentially improving health outcomes for many Americans. It reflects a growing recognition of the importance of affordable healthcare solutions.

Read full article

via Financial Times